Sarah E. Lochrin (@lochrinsarah) 's Twitter Profile
Sarah E. Lochrin

@lochrinsarah

Irish Medical Oncology Fellow at MSKCC

ID: 1397280255413559300

calendar_today25-05-2021 19:56:05

45 Tweet

179 Followers

183 Following

Sarah E. Lochrin (@lochrinsarah) 's Twitter Profile Photo

Amazing work by Ronan Andrew McLaughlin looking at the association of the gut microbiome diversity in pCR after neoadjuvant treatment in esophageal and rectal ca. Well done to all involved

Amazing work by <a href="/RonanAndrewMcL1/">Ronan Andrew McLaughlin</a> looking at the association of the gut microbiome diversity in pCR after neoadjuvant treatment in esophageal and rectal ca. Well done to all involved
Patrick Forde (@fordepatrick) 's Twitter Profile Photo

Anyone following #esmo23 virtually or any insomniacs like myself, please join the outstanding Dr. Sarah E. Lochrin (& me, both from 🇮🇪!) as we discuss #mesothelioma in a tumor board format this Tuesday night 8pm US Eastern time (1-2am Wed Western Europe, 9am wed Aus/Asia). Mesothelioma Applied Research Foundation

#TumorBoardTuesday (@tumorboardtues) 's Twitter Profile Photo

☘️#ESMO23 developments + updates on #Mesothelioma treatments are perfect timing for this week’s #TumorBoardTuesday! 🇮🇪Patrick Forde Sarah E. Lochrin are teaming up & putting finishing touches on their #LungCancer case 🫁Join us 10/24 at 8pm ET here! #CME integrityce.com/TBT2023👈🏼

☘️#ESMO23 developments + updates on #Mesothelioma treatments are perfect timing for this week’s #TumorBoardTuesday!

🇮🇪<a href="/FordePatrick/">Patrick Forde</a> <a href="/LochrinSarah/">Sarah E. Lochrin</a> are teaming up &amp; putting finishing touches on their #LungCancer case

🫁Join us 10/24 at 8pm ET here!
#CME integrityce.com/TBT2023👈🏼
#TumorBoardTuesday (@tumorboardtues) 's Twitter Profile Photo

#PreTest Q1️⃣ #TumorBoardTuesday Free #CME integrityce.com/TBT2023 ➡️B4🇮🇪Patrick Forde & Sarah E. Lochrin🍀🧑‍🏫us about Tx4⃣Mesothelioma, test your🧠with these Q’s 🤔 What would be your1⃣st Tx for a 66yo♂️w/a new stage 3B pleural mesothelioma (biphasic, 80% sarcomatoid), ECOG PS=0❓

#TumorBoardTuesday (@tumorboardtues) 's Twitter Profile Photo

#TumorBoardTuesday #PreTest Q2️⃣ #CME 👉🏽CME Eval 🔗 integrityce.com/TBTeval23 👉🏽ALL CME🔗 integrityce.com/TBT2023 🤔Which immune✅point⛔️, in combo w/ platinum-doublet chemotherapy, significantly⬆️overall survival in patients with chemotherapy-naïve pleural mesothelioma❓

Sarah E. Lochrin (@lochrinsarah) 's Twitter Profile Photo

Delighted to present our work on melanoma brain metastases post PD-1 and germline variants in melanoma today, great discussions & insights. Lucky to work with such fantastic colleagues and mentors. #ASCO24 Memorial Sloan Kettering Cancer Center, Alex Shoushtari, MD, Michael Postow, Jim Smithy, Zsofia Stadler

Delighted to present our work on melanoma brain metastases post PD-1 and germline variants in melanoma today, great discussions &amp; insights. Lucky to work with such fantastic colleagues and mentors. #ASCO24
<a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a>, <a href="/alexshoushtari/">Alex Shoushtari, MD</a>, <a href="/MPostow/">Michael Postow</a>, <a href="/jsmithymd/">Jim Smithy</a>, <a href="/StadlerZsofia/">Zsofia Stadler</a>